156 related articles for article (PubMed ID: 11641245)
1. The pregnancy hormone relaxin is a player in human heart failure.
Dschietzig T; Richter C; Bartsch C; Laule M; Armbruster FP; Baumann G; Stangl K
FASEB J; 2001 Oct; 15(12):2187-95. PubMed ID: 11641245
[TBL] [Abstract][Full Text] [Related]
2. Effect of relaxin on myocardial ischemia injury induced by isoproterenol.
Zhang J; Qi YF; Geng B; Pan CS; Zhao J; Chen L; Yang J; Chang JK; Tang CS
Peptides; 2005 Sep; 26(9):1632-9. PubMed ID: 16112403
[TBL] [Abstract][Full Text] [Related]
3. The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease.
Heringlake M; Kox T; Poeling J; Klaus S; Hanke T; Franz N; Eberhardt F; Heinze H; Armbruster FP; Bahlmann L
Eur J Med Res; 2009 Mar; 14(3):106-12. PubMed ID: 19380280
[TBL] [Abstract][Full Text] [Related]
4. Physiological or pathological--a role for relaxin in the cardiovascular system?
Samuel CS; Parry LJ; Summers RJ
Curr Opin Pharmacol; 2003 Apr; 3(2):152-8. PubMed ID: 12681237
[TBL] [Abstract][Full Text] [Related]
5. Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration.
Nistri S; Pini A; Sassoli C; Squecco R; Francini F; Formigli L; Bani D
J Cell Mol Med; 2012 Mar; 16(3):507-19. PubMed ID: 21554533
[TBL] [Abstract][Full Text] [Related]
6. Characterization and biological activity of relaxin in porcine milk.
Frankshun AL; Ho TY; Reimer DC; Chen J; Lasano S; Steinetz BG; Bartol FF; Bagnell CA
Reproduction; 2011 Mar; 141(3):373-80. PubMed ID: 21177955
[TBL] [Abstract][Full Text] [Related]
7. Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure.
Zheng G; Cai J; Chen X; Chen L; Ge W; Zhou X; Zhou H
Biol Pharm Bull; 2017; 40(7):960-966. PubMed ID: 28674260
[TBL] [Abstract][Full Text] [Related]
8. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype.
Du XJ; Samuel CS; Gao XM; Zhao L; Parry LJ; Tregear GW
Cardiovasc Res; 2003 Feb; 57(2):395-404. PubMed ID: 12566112
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional evaluation of relaxin and endothelin-1 axis in heart failure patients: First evidence of its involvement during left ventricular assist device support.
Cabiati M; Botta L; Caselli C; Del Ry S
Int J Cardiol; 2020 May; 306():109-115. PubMed ID: 32143920
[TBL] [Abstract][Full Text] [Related]
10. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis.
Samuel CS; Zhao C; Bond CP; Hewitson TD; Amento EP; Summers RJ
Kidney Int; 2004 Jun; 65(6):2054-64. PubMed ID: 15149318
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway.
Masini E; Zagli G; Ndisang JF; Solazzo M; Mannaioni PF; Bani D
Br J Pharmacol; 2002 Oct; 137(3):337-44. PubMed ID: 12237253
[TBL] [Abstract][Full Text] [Related]
12. Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy.
Samuel CS; Hewitson TD; Zhang Y; Kelly DJ
Endocrinology; 2008 Jul; 149(7):3286-93. PubMed ID: 18388190
[TBL] [Abstract][Full Text] [Related]
13. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells.
Failli P; Nistri S; Quattrone S; Mazzetti L; Bigazzi M; Sacchi TB; Bani D
FASEB J; 2002 Feb; 16(2):252-4. PubMed ID: 11744624
[TBL] [Abstract][Full Text] [Related]
14. Relaxin is a potent renal vasodilator in conscious rats.
Danielson LA; Sherwood OD; Conrad KP
J Clin Invest; 1999 Feb; 103(4):525-33. PubMed ID: 10021461
[TBL] [Abstract][Full Text] [Related]
15. The effect of relaxin on the oxytocin receptor in human uterine smooth muscle cells.
Friebe-Hoffmann U; Baston DM; Chiao JP; Winebrenner LD; Krüssel JS; Hoffmann TK; Hirchenhain J; Rauk PN
Regul Pept; 2007 Feb; 138(2-3):74-81. PubMed ID: 17055075
[TBL] [Abstract][Full Text] [Related]
16. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
17. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.
Dschietzig T; Bartsch C; Baumann G; Stangl K
Pharmacol Ther; 2006 Oct; 112(1):38-56. PubMed ID: 16647137
[TBL] [Abstract][Full Text] [Related]
18. Disparate effects of relaxin and TGFbeta1: relaxin increases, but TGFbeta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells.
Mazella J; Tang M; Tseng L
Hum Reprod; 2004 Jul; 19(7):1513-8. PubMed ID: 15155604
[TBL] [Abstract][Full Text] [Related]
19. Relaxin: new functions for an old peptide.
Baccari MC; Calamai F
Curr Protein Pept Sci; 2004 Feb; 5(1):9-18. PubMed ID: 14965317
[TBL] [Abstract][Full Text] [Related]
20. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
